<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:31:14Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9015007" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9015007</identifier>
        <datestamp>2022-04-20</datestamp>
        <setSpec>brb</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="brb32475" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Brain Behav</journal-id>
              <journal-id journal-id-type="iso-abbrev">Brain Behav</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2157-9032</journal-id>
              <journal-id journal-id-type="publisher-id">BRB3</journal-id>
              <journal-title-group>
                <journal-title>Brain and Behavior</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2162-3279</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9015007</article-id>
              <article-id pub-id-type="pmcid">PMC9015007</article-id>
              <article-id pub-id-type="pmc-uid">9015007</article-id>
              <article-id pub-id-type="pmid">35233974</article-id>
              <article-id pub-id-type="pmid">35233974</article-id>
              <article-id pub-id-type="doi">10.1002/brb3.2475</article-id>
              <article-id pub-id-type="publisher-id">BRB32475</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Default mode network connectivity and treatment response in geriatric depression</article-title>
                <alt-title alt-title-type="left-running-head">KILPATRICK et al.</alt-title>
                <alt-title alt-title-type="right-running-head">DMN and treatment response in GD</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="brb32475-cr-0001" contrib-type="author">
                  <name>
                    <surname>Kilpatrick</surname>
                    <given-names>Lisa A.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2148-5214</contrib-id>
                  <xref rid="brb32475-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="brb32475-cr-0002" contrib-type="author">
                  <name>
                    <surname>Krause‐Sorio</surname>
                    <given-names>Beatrix</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5495-6348</contrib-id>
                  <xref rid="brb32475-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="brb32475-cr-0003" contrib-type="author">
                  <name>
                    <surname>Siddarth</surname>
                    <given-names>Prabha</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8746-6353</contrib-id>
                  <xref rid="brb32475-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="brb32475-cr-0004" contrib-type="author">
                  <name>
                    <surname>Narr</surname>
                    <given-names>Katherine L.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9396-7936</contrib-id>
                  <xref rid="brb32475-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="brb32475-cr-0005" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Lavretsky</surname>
                    <given-names>Helen</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9990-5085</contrib-id>
                  <xref rid="brb32475-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <address>
                    <email>hlavretsky@mednet.ucla.edu</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="brb32475-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">G. Oppenheimer Family Center for Neurobiology of Stress and Resilience</named-content>
                <named-content content-type="organisation-division">Vatche and Tamar Manoukian Division of Digestive Diseases</named-content>
                <institution>David Geffen School of Medicine at University of California</institution>
                <city>Los Angeles</city>
                <named-content content-type="country-part">California</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="brb32475-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Jane and Terry Semel Institute for Neuroscience and Human Behavior</named-content>
                <institution>University of California</institution>
                <city>Los Angeles</city>
                <named-content content-type="country-part">California</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="brb32475-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Brain Mapping Center</named-content>
                <named-content content-type="organisation-division">Departments of Neurology</named-content>
                <institution>and Psychiatry and Biobehavioral Sciences</institution>
                <city>Los Angeles</city>
                <named-content content-type="country-part">California</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>Helen Lavretsky, Professor of Psychiatry in Residence, Director, Late‐Life Mood, Stress, and Wellness Research Program, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at University of California Los Angeles, 760 Westwood Plaza, Los Angeles, CA 90095, USA.<break/>Email: <email>hlavretsky@mednet.ucla.edu</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>01</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>4</month>
                <year>2022</year>
              </pub-date>
              <volume>12</volume>
              <issue seq="30">4</issue>
              <issue-id pub-id-type="doi">10.1002/brb3.v12.4</issue-id>
              <elocation-id>e2475</elocation-id>
              <history>
                <date date-type="rev-recd">
                  <day>09</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
                <date date-type="received">
                  <day>10</day>
                  <month>2</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>08</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2022 Published by Wiley Periodicals LLC-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. <italic toggle="yes">Brain and Behavior</italic> published by Wiley Periodicals LLC</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:BRB3-12-e2475.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="brb32475-sec-0010">
                  <title>Objectives</title>
                  <p>Default mode network (DMN) connectivity is altered in depression. We evaluated the relationship between changes in within‐network DMN connectivity and improvement in depression in a subsample of our parent clinical trial comparing escitalopram/memantine (ESC/MEM) to escitalopram/placebo (ESC/PBO) in older depressed adults (NCT01902004).</p>
                </sec>
                <sec id="brb32475-sec-0020">
                  <title>Methods</title>
                  <p>Twenty‐six participants with major depression (age &gt; 60 years) and subjective memory complaints underwent treatment with ESC/MEM (<italic toggle="yes">n</italic> = 13) or ESC/PBO (<italic toggle="yes">n</italic> = 13), and completed baseline and 3‐month follow‐up resting state magnetic resonance imaging scans. Multi‐block partial least squares correlation analysis was used to evaluate the impact of treatment on within‐network DMN connectivity changes and their relationship with symptom improvement at 3 months (controlling for age and sex).</p>
                </sec>
                <sec id="brb32475-sec-0030">
                  <title>Results</title>
                  <p>A significant latent variable was identified, reflecting within‐network DMN connectivity changes correlated with symptom improvement (<italic toggle="yes">p</italic> = .01). Specifically, although overall group differences in within‐network DMN connectivity changes failed to reach significance, increased within‐network connectivity of posterior/lateral DMN regions (precuneus, angular gyrus, superior/middle temporal cortex) was more strongly and positively correlated with symptom improvement in the ESC/MEM group (<italic toggle="yes">r</italic> = 0.97, 95% confidence interval: 0.86–0.98) than in the ESC/PBO group (<italic toggle="yes">r</italic> = 0.36, 95% confidence interval: 0.13–0.72).</p>
                </sec>
                <sec id="brb32475-sec-0040">
                  <title>Conclusions</title>
                  <p>Increased within‐network connectivity of core DMN nodes was more strongly correlated with depressive symptom improvement with ESC/MEM than with ESC/PBO, supporting an improved engagement of brain circuitry implicated in the amelioration of depressive symptoms with combined ESC/MEM treatment in older adults with depression and subjective memory complaints.</p>
                </sec>
              </abstract>
              <abstract id="brb32475-abs-0001" abstract-type="short">
                <p>We evaluated the relationship between changes in DMN connectivity and improvement in depression in a subsample of our parent clinical trial comparing escitalopram/memantine (ESC/MEM) to escitalopram/placebo (ESC/PBO) in older depressed adults (NCT01902004). A significant latent variable was identified, reflecting DMN connectivity changes related to symptom improvement. Increased connectivity of core DMN nodes was more strongly associated with depressive symptom improvement with ESC/MEM than with ESC/PBO, supporting a neuroplastic effect of memantine addition to escitalopram on brain circuitry that can help reduce depressive symptoms and prevent cognitive decline.</p>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="brb32475-kwd-0001">default mode network</kwd>
                <kwd id="brb32475-kwd-0002">depression</kwd>
                <kwd id="brb32475-kwd-0003">memory</kwd>
                <kwd id="brb32475-kwd-0004">randomized controlled trial</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>NIH
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01MH097892</award-id>
                  <award-id>AT009198</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>National Center for Advancing Translational Science (NCATS) UCLA CTSI</funding-source>
                  <award-id>UL1TR001881</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="2"/>
                <page-count count="7"/>
                <word-count count="4985"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>April 2022</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.4 mode:remove_FC converted:18.04.2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="brb32475-cit-0040"><string-name><surname>Kilpatrick</surname>, <given-names>L. A.</given-names></string-name>, <string-name><surname>Krause‐Sorio</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Siddarth</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Narr</surname>, <given-names>K. L.</given-names></string-name>, &amp; <string-name><surname>Lavretsky</surname>, <given-names>H.</given-names></string-name> (<year>2022</year>). <article-title>Default mode network connectivity and treatment response in geriatric depression</article-title>. <source>Brain and Behavior</source>, <volume>12</volume>, <elocation-id>e2475</elocation-id>. <pub-id pub-id-type="doi">10.1002/brb3.2475</pub-id>
</mixed-citation>
              </p>
            </notes>
          </front>
          <body>
            <sec id="brb32475-sec-0050">
              <label>1</label>
              <title>INTRODUCTION</title>
              <p>Late‐life depression (LLD) is common, affecting 10–15% of individuals aged 60 years and older (Ismail et al., <xref rid="brb32475-bib-0017" ref-type="bibr">2013</xref>), and is associated with cognitive impairment, including memory impairments, which can persist after successful treatment for depression (Diniz et al., <xref rid="brb32475-bib-0005" ref-type="bibr">2013</xref>; Mitchell &amp; Subramaniam, <xref rid="brb32475-bib-0027" ref-type="bibr">2005</xref>; Nebes et al., <xref rid="brb32475-bib-0030" ref-type="bibr">2003</xref>; Singh‐Manoux et al., <xref rid="brb32475-bib-0035" ref-type="bibr">2017</xref>; Wilkins et al., <xref rid="brb32475-bib-0036" ref-type="bibr">2009</xref>). Older adults with both mild cognitive impairment and depression are more likely to develop dementia than those with mild cognitive impairment only (Mourao et al., <xref rid="brb32475-bib-0029" ref-type="bibr">2016</xref>). Additionally, endorsement of subjective memory complaints is associated with increased risk for mild cognitive impairment and dementia. These findings suggest that treatment strategies targeting both depression and memory impairment in its early stages are needed. Memantine (MEM) is a non‐competitive N‐methyl‐D‐aspartate receptor (NMDAR) antagonist that is currently FDA‐approved for the treatment of cognitive symptoms in dementia (McShane et al., <xref rid="brb32475-bib-0026" ref-type="bibr">2006</xref>). In a double‐blind, randomized placebo‐controlled trial of geriatric major depression with subjective memory complaints (NCT01902004), we previously showed that although escitalopram combined with MEM (ESC/MEM) and ESC combined with placebo (ESC/PBO) both showed improvement in mood, ESC/MEM was more effective than ESC/PBO in improving cognitive outcomes at 12 months (Lavretsky et al., <xref rid="brb32475-bib-0021" ref-type="bibr">2020</xref>).</p>
              <p>The default mode network (DMN) is a large‐scale brain network, mainly comprising the precuneus and posterior cingulate cortex (posterior DMN), medial prefrontal cortex (anterior DMN), and inferior parietal lobe and lateral temporal cortex (lateral DMN), that is involved in a variety of functions, including social cognition, episodic memory, and self‐referential processes (Greicius &amp; Menon, <xref rid="brb32475-bib-0010" ref-type="bibr">2004</xref>; Gusnard et al., <xref rid="brb32475-bib-0012" ref-type="bibr">2001</xref>; Iacoboni et al., <xref rid="brb32475-bib-0016" ref-type="bibr">2004</xref>). DMN alterations are thought to play an important role in the pathophysiology of major depressive disorders (MDD). Although early studies on the DMN in MDD, and specifically LLD, largely reported increased connectivity within the DMN (either between specific nodes in region of interest analyses or between specific nodes and the DMN as a whole in independent component analyses; hitherto referred to as within‐network DMN connectivity) (Andreescu et al., <xref rid="brb32475-bib-0001" ref-type="bibr">2013</xref>; Hamilton et al., <xref rid="brb32475-bib-0014" ref-type="bibr">2015</xref>; Kaiser et al., <xref rid="brb32475-bib-0018" ref-type="bibr">2015</xref>; Li et al., <xref rid="brb32475-bib-0022" ref-type="bibr">2013</xref>), a more recent large‐scale study found decreased within‐network DMN connectivity as associated with recurrent MDD and antidepressant use (Yan et al., <xref rid="brb32475-bib-0039" ref-type="bibr">2019</xref>). Furthermore, treatment studies of major depression in both younger and older adults have shown that changes in within‐network DMN connectivity with antidepressant treatment are complex, and can differ depending on treatment response (Andreescu et al., <xref rid="brb32475-bib-0001" ref-type="bibr">2013</xref>; Karim et al., <xref rid="brb32475-bib-0019" ref-type="bibr">2017</xref>; Li et al., <xref rid="brb32475-bib-0022" ref-type="bibr">2013</xref>).</p>
              <p>In the present study, we aimed to evaluate the changes in DMN connectivity following 3 months of treatment with ESC/MEM or ESC/PBO, as well as, the relationship between DMN connectivity changes and changes in depressive symptoms, in adults with LLD and subjective memory complaints. We hypothesized that ESC/MEM treatment would show more pronounced changes in within‐network DMN connectivity, associated with greater depressive symptom improvement.</p>
            </sec>
            <sec id="brb32475-sec-0060">
              <label>2</label>
              <title>MATERIALS AND METHODS</title>
              <sec id="brb32475-sec-0070">
                <label>2.1</label>
                <title>Participants</title>
                <p>Twenty‐six older adults (age &gt; 60 years) diagnosed with MDD who participated in a parent randomized placebo‐controlled clinical trial (RCT; NCT01902004) of combined escitalopram‐memantine (ESC/MEM) versus escitalopram‐placebo (ESC/PBO) (Lavretsky et al., <xref rid="brb32475-bib-0021" ref-type="bibr">2020</xref>) and completed resting‐state magnetic resonance imaging (rsMRI) at baseline and 3 months of follow up (total <italic toggle="yes">N</italic> = 26, ESC/MEM, <italic toggle="yes">N</italic> = 13; ESC/PBO, <italic toggle="yes">N</italic> = 13) were included. The placebo comprised a capsule containing an inert substance. Eligibility criteria for the RCT were as follows: 1) At least 60 years of age; 2) a diagnosis of MDD according to the Diagnostic and Statistical Manual (DSM‐5) diagnostic criteria (APA Association, <xref rid="brb32475-bib-0002" ref-type="bibr">2013</xref>) and a score of at least 16 on Hamilton Rating Scale for Depression (Hamilton, <xref rid="brb32475-bib-0015" ref-type="bibr">1960</xref>); 3) an absence of dementia, determined by neurological evaluations, neuropsychological evaluations, laboratory tests (see Lavretsky et al., <xref rid="brb32475-bib-0021" ref-type="bibr">2020</xref> for details) and a score &gt; 23 on the Mini‐Mental State Examination (Folstein et al., <xref rid="brb32475-bib-0008" ref-type="bibr">1975</xref>); and 4) subjectively reported memory impairment. Exclusion criteria were as follows: 1) A prior history of psychiatric disorders, such as, substance abuse disorder, suicidal behavior, or suicide attempts in the past year; 2) acute, severe, or recent medical illness; and 3) a history of allergies or intolerance to either escitalopram or memantine. Additionally, participants who consented to the neuroimaging component could not have any MRI‐incompatible implants or other imaging contra‐indications. None of the participants took cognitive enhancers at study entry.</p>
                <p>The study was approved by the UCLA Institutional Review Board, and written informed consent was obtained from all participants.</p>
              </sec>
              <sec id="brb32475-sec-0080">
                <label>2.2</label>
                <title>Study design</title>
                <p>Details regarding the study protocol have been previously described (Lavretsky et al., <xref rid="brb32475-bib-0021" ref-type="bibr">2020</xref>). Participants remained free from psychotropic medication for at least two weeks before baseline assessments (four weeks if they had previously taken fluoxetine). The daily dose of escitalopram was 10 mg for the first four weeks of administration, and was increased to 20 mg after four weeks if the Clinical Global Impression Scale (Guy, <xref rid="brb32475-bib-0013" ref-type="bibr">1976</xref>) score was at least 3. The daily dose of memantine or matched placebo was gradually increased from 5 to 20 mg over the course of four weeks. Daily study drug doses were adjusted to a minimum of 5 mg for memantine and 10 mg of escitalopram, based on tolerability.</p>
                <p>Baseline and 3‐month follow‐up assessments included the Montgomery‐Asberg Depression Rating Scale (MADRS) (Montgomery &amp; Asberg, <xref rid="brb32475-bib-0028" ref-type="bibr">1979</xref>) as a measure of depressive symptom severity, which has been shown to be sensitive to combined ESC/MEM treatment (Lavretsky et al., <xref rid="brb32475-bib-0021" ref-type="bibr">2020</xref>). Symptom improvement scores were calculated as follows: (−1 X (3‐month score—baseline score)).</p>
              </sec>
              <sec id="brb32475-sec-0090">
                <label>2.3</label>
                <title>Neuroimaging</title>
                <p>MRI‐eligible participants underwent scanning at baseline and the 3‐month follow up. A high‐resolution T1‐weighted MRI image and resting state BOLD images were collected using either a 3T Siemens TIM Trio (ESC/MEM: <italic toggle="yes">n</italic> = 5; ESC/PBO; <italic toggle="yes">n</italic> = 7) or Prisma‐fit system (Siemens, Erlangen, Germany; ESC/MEM: <italic toggle="yes">n</italic> = 8; ESC/PBO; <italic toggle="yes">n</italic> = 6) with a 32‐channel head coil. For each participant, baseline and follow‐up scans were collected on the same MRI system. The multi‐echo MPRAGE scan was collected using the following parameters, matched across scanners: Isotropic 1‐mm<sup>3</sup> (Trio) or 0.8‐mm<sup>3</sup> (Prisma) voxels; 176 (Trio) or 208 (Prisma) slices; TR 2150 (Trio) or 2400 (Prisma) ms; TE, 1.74, 3.6, 5.46, and 7.32 (Trio) or 2.24 (Prisma) ms; TI, 1260 (Trio) or 1060 (Prisma); FOV, 256 mm; matrix size, 256 × 256 (Trio) or 256 × 240 (Prisma) mm; and flip angle, 7 (Trio) or 8 (Prisma) degrees. The 5.7‐min (Trio)/7.3‐min (Prisma) resting state scan (eyes closed) was collected using the following parameters, matched across scanners: isotropic 1.8‐mm<sup>3</sup> voxels; 78 slices; TR 1240 (Trio) or 1595 (Prisma) ms; TE, 38.2 (Trio) or 49.8 (Prisma) ms; FOV, 212 (Trio) or 213 (Prisma) mm; matrix size, 212 × 212 (Trio) or 213 × 213 (Prisma) mm; and flip angle, 65°.</p>
                <p>Image quality was assessed using MRIQC (Esteban et al., <xref rid="brb32475-bib-0006" ref-type="bibr">2017</xref>). Imaging data were pre‐processed using fMRIPREP version 1.4.1rc1 (RRID:SCR_016216) (Esteban et al., <xref rid="brb32475-bib-0007" ref-type="bibr">2019</xref>). Resting state data were motion corrected, followed by co‐registration to the corresponding T1‐weighted structural scan and normalization to MNI space. The data was smoothed with a kernel width of 6 mm, and independent component analysis‐based automatic removal of motion artifacts (ICA‐AROMA) was used to non‐aggressively denoise the data (Pruim et al., <xref rid="brb32475-bib-0034" ref-type="bibr">2015</xref>). Preprocessing results were visually inspected using the summary reports provided by fMRIPREP (Esteban et al., <xref rid="brb32475-bib-0007" ref-type="bibr">2019</xref>). Group‐ICA was implemented with the FSL multivariate exploratory linear optimized decomposition into independent components (MELODIC) algorithm with a dimensionality of 25 (<ext-link xlink:href="http://www.fmrib.ox.ac.uk/fsl/melodic/index.html" ext-link-type="uri">http://www.fmrib.ox.ac.uk/fsl/melodic/index.html</ext-link>) (Beckmann &amp; Smith, <xref rid="brb32475-bib-0003" ref-type="bibr">2005</xref>). A single DMN component, comprising both anterior and posterior DMN key nodes (precuneus and medial prefrontal cortices), was identified (Figure <xref rid="brb32475-fig-0001" ref-type="fig">1</xref>). Dual regression was performed to create individual‐participant DMN parameter estimate maps (Nickerson et al., <xref rid="brb32475-bib-0031" ref-type="bibr">2017</xref>). For each participant, the 3‐month change in within‐network DMN connectivity was calculated by subtracting the baseline DMN map from the 3‐month DMN map.</p>
                <fig position="float" fig-type="FIGURE" id="brb32475-fig-0001">
                  <label>FIGURE 1</label>
                  <caption>
                    <p>The DMN mask used in the partial least squares correlation analysis, identified by group independent component analysis</p>
                  </caption>
                  <graphic xlink:href="BRB3-12-e2475-g001" position="anchor" id="jats-graphic-1"/>
                </fig>
              </sec>
              <sec id="brb32475-sec-0100">
                <label>2.4</label>
                <title>Statistical analysis</title>
                <p>Group differences in clinical characteristics were evaluated using the non‐parametric Kruskal‐Wallis test for continuous variables and the Fisher's exact test for categorical variables. Group differences in baseline within‐network DMN connectivity were evaluated in an unpaired t‐test using randomize in FSL (Winkler et al., <xref rid="brb32475-bib-0037" ref-type="bibr">2014</xref>). Partial least squares correlation (PLSC) analysis was applied to simultaneously evaluate group differences in DMN connectivity changes and the relationships between DMN connectivity changes and symptom improvement at 3 months. PLSC is a multivariate statistical technique that identifies relationships between patterns in two or more blocks of variables (e.g., neuroimaging data, behavioral/group data) and is considered more sensitive than traditional univariate approaches (Krishnan et al., <xref rid="brb32475-bib-0020" ref-type="bibr">2011</xref>; McIntosh &amp; Lobaugh, <xref rid="brb32475-bib-0025" ref-type="bibr">2004</xref>; McIntosh et al., <xref rid="brb32475-bib-0024" ref-type="bibr">1996</xref>). In PLSC, latent variables, comprising a set of spatial maps with associated weightings for each group/behavioral measure, are produced. PLSC was implemented using freely available code (<ext-link xlink:href="http://www.rotman-baycrest.on.ca/pls" ext-link-type="uri">http://www.rotman‐baycrest.on.ca/pls</ext-link>) (McIntosh et al., <xref rid="brb32475-bib-0024" ref-type="bibr">1996</xref>)<sup>.</sup> Sex‐ and age‐adjusted individual‐participant DMN maps and the 3‐month improvement in MADRS scores were submitted as input to the PLSC analysis, and to limit the analysis to regions within the DMN, a mask of the brain regions with positive weights on the group DMN map produced by the ICA analysis was applied. Significance of each latent variable was assessed using permutation testing (5000 permutations), and voxel reliability was assessed using bootstrap estimation (5000 samples) (McIntosh et al., <xref rid="brb32475-bib-0024" ref-type="bibr">1996</xref>). Clusters with a peak voxel bootstrap standard error ratio (BSR) exceeding ±3.3 (<italic toggle="yes">p</italic> &lt; .001) and an extent of at least 125 voxels are reported. For all other measures, <italic toggle="yes">p</italic> &lt; .05 was considered statistically significant.</p>
              </sec>
            </sec>
            <sec id="brb32475-sec-0110">
              <label>3</label>
              <title>RESULTS</title>
              <sec id="brb32475-sec-0120">
                <label>3.1</label>
                <title>Baseline data</title>
                <p>Baseline demographics and clinical data are summarized in Table <xref rid="brb32475-tbl-0001" ref-type="table">1</xref>. There were no significant baseline differences between groups in demographics (age, sex, education, and ethnicity) and clinical data (Mini‐Mental State Examination, diagnosis of MCI, depressive and cognitive measures).</p>
                <table-wrap position="float" id="brb32475-tbl-0001" content-type="TABLE">
                  <label>TABLE 1</label>
                  <caption>
                    <p>Baseline characteristics according to group</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th style="border-bottom:solid 1px #000000" align="left" colspan="2" rowspan="1">
                          <bold>ESC/MEM (<italic toggle="yes">n</italic> = 13)</bold>
                        </th>
                        <th style="border-bottom:solid 1px #000000" align="left" colspan="2" rowspan="1">
                          <bold>ESC/PBO (<italic toggle="yes">n</italic> = 13)</bold>
                        </th>
                        <th align="left" rowspan="1" colspan="1">
                          <bold>Statistics</bold>
                        </th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">
                          <bold>Variable</bold>
                        </th>
                        <th align="left" rowspan="1" colspan="1">N</th>
                        <th align="left" rowspan="1" colspan="1">%</th>
                        <th align="left" rowspan="1" colspan="1">N</th>
                        <th align="left" rowspan="1" colspan="1">%</th>
                        <th align="left" rowspan="1" colspan="1">Fisher's exact test</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Sex: Female</td>
                        <td align="char" rowspan="1" colspan="1">7</td>
                        <td align="char" rowspan="1" colspan="1">53.85</td>
                        <td align="char" rowspan="1" colspan="1">8</td>
                        <td align="char" rowspan="1" colspan="1">61.54</td>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &gt; .99</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Race/ethnicity</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &gt; .99</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Caucasian</td>
                        <td align="char" rowspan="1" colspan="1">10</td>
                        <td align="char" rowspan="1" colspan="1">76.92</td>
                        <td align="char" rowspan="1" colspan="1">11</td>
                        <td align="char" rowspan="1" colspan="1">84.62</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Hispanic</td>
                        <td align="char" rowspan="1" colspan="1">3</td>
                        <td align="char" rowspan="1" colspan="1">23.08</td>
                        <td align="char" rowspan="1" colspan="1">2</td>
                        <td align="char" rowspan="1" colspan="1">15.38</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Diagnosis of MCI</td>
                        <td align="char" rowspan="1" colspan="1">2</td>
                        <td align="char" rowspan="1" colspan="1">15.38</td>
                        <td align="char" rowspan="1" colspan="1">2</td>
                        <td align="char" rowspan="1" colspan="1">15.38</td>
                        <td align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic> &gt; .99</td>
                      </tr>
                    </tbody>
                  </table>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="left" rowspan="1" colspan="1">M</th>
                        <th align="left" rowspan="1" colspan="1">SD</th>
                        <th align="left" rowspan="1" colspan="1">M</th>
                        <th align="left" rowspan="1" colspan="1">SD</th>
                        <th align="left" rowspan="1" colspan="1">Kruskal‐Wallis test</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age (years)</td>
                        <td align="char" rowspan="1" colspan="1">70.38</td>
                        <td align="char" rowspan="1" colspan="1">7.56</td>
                        <td align="char" rowspan="1" colspan="1">69.54</td>
                        <td align="char" rowspan="1" colspan="1">7.46</td>
                        <td align="left" rowspan="1" colspan="1">χ2(1) = 0.04, <italic toggle="yes">p </italic>= .84</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Education (years)</td>
                        <td align="char" rowspan="1" colspan="1">15.77</td>
                        <td align="char" rowspan="1" colspan="1">2.28</td>
                        <td align="char" rowspan="1" colspan="1">15.93</td>
                        <td align="char" rowspan="1" colspan="1">2.22</td>
                        <td align="left" rowspan="1" colspan="1">χ2(1) = 0.14, <italic toggle="yes">p</italic> = .71</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">MMSE</td>
                        <td align="char" rowspan="1" colspan="1">28.92</td>
                        <td align="char" rowspan="1" colspan="1">.95</td>
                        <td align="char" rowspan="1" colspan="1">28.08</td>
                        <td align="char" rowspan="1" colspan="1">1.66</td>
                        <td align="left" rowspan="1" colspan="1">χ2(1) = 1.83, <italic toggle="yes">p</italic> = .18</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">MADRS</td>
                        <td align="char" rowspan="1" colspan="1">16.62</td>
                        <td align="char" rowspan="1" colspan="1">2.43</td>
                        <td align="char" rowspan="1" colspan="1">15.54</td>
                        <td align="char" rowspan="1" colspan="1">2.82</td>
                        <td align="left" rowspan="1" colspan="1">χ2(1) = 1.75, <italic toggle="yes">p </italic>= .19</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="brb32475-tbl1-note-0001">
                      <p>Abbreviations: ESC, Escitalopram; MEM, Memantine; PBO, Placebo; MCI, Mild Cognitive Impairment; MMSE, Mini‐Mental State Examination; MADRS, Montgomery–Åsberg Depression Rating Scale.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="brb32475-sec-0130">
                <label>3.2</label>
                <title>Symptom improvement</title>
                <p>Although the post‐treatment improvement in MADRS scores relative to the pretreatment score was greater in the ESC/MEM group (mean ± standard deviation: −10.23 ± 6.17) than in the ESC/PBO group (−6.62 ± 3.97), the group difference failed to reach significance (χ<sup>2</sup>(1) = 3.45; <italic toggle="yes">p</italic> = .06).</p>
              </sec>
              <sec id="brb32475-sec-0140">
                <label>3.3</label>
                <title>Within‐network default mode network connectivity</title>
                <p>There were no significant group differences in baseline within‐network DMN connectivity. However, the PLSC analysis identified a single significant latent variable (accounting for 24.9% of the cross‐block variance, <italic toggle="yes">p</italic> = .01), reflecting a non‐significant group difference in within‐network DMN connectivity changes and a significant group difference in the relationship between within‐network DMN connectivity changes and symptom improvement. Specifically, the PLSC identified a set of regions that tended to show larger within‐network DMN connectivity changes in the ESC/MEM group than in the ESC/PBO group; however, the group difference failed to reach significance. In these same regions, increased within‐network connectivity was significantly more positively correlated symptom improvement in the ESC/MEM group (<italic toggle="yes">r</italic> = 0.97, 95% confidence interval: 0.86–0.98) than in the ESC/PBO group (<italic toggle="yes">r</italic> = 0.36, 95% confidence interval: 0.13 to 0.72). Additionally, in this set of regions, the group difference in relationship between within‐network DMN connectivity changes and symptom improvement remained significant when controlling for scanner type (partial correlation with bootstrapping; ESC/MEM group: <italic toggle="yes">r</italic> = 0.97, 95% confidence interval: 0.79–0.99; ESC/PBO group: <italic toggle="yes">r</italic> = 0.13; 95% confidence interval: −0.38 to 0.74). Regions reliably contributing to this pattern included several core DMN regions (precuneus, angular gyrus, and middle/superior temporal cortex) (Table <xref rid="brb32475-tbl-0002" ref-type="table">2</xref>, Figure <xref rid="brb32475-fig-0002" ref-type="fig">2</xref>). In the PLSC analysis, no areas with negative weights on the identified latent variable (indicating decreased DMN connectivity as more positively correlated symptom improvement in the ESC/MEM group than in the ESC/PBO group) survived the bootstrap estimation of reliability.</p>
                <table-wrap position="float" id="brb32475-tbl-0002" content-type="TABLE">
                  <label>TABLE 2</label>
                  <caption>
                    <p>Regions reliably showing a stronger correlation between within‐network connectivity increases and symptom improvement in the ESC/MEM group than in the ESC/PBO group</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">
                          <bold>Region</bold>
                        </th>
                        <th align="left" rowspan="1" colspan="1">
                          <bold>MNI cords</bold>
                        </th>
                        <th align="left" rowspan="1" colspan="1">
                          <bold>BSR</bold>
                        </th>
                        <th align="left" rowspan="1" colspan="1">
                          <bold>Cluster size</bold>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">R middle temporal gyrus</td>
                        <td align="left" rowspan="1" colspan="1">56 −2 −16</td>
                        <td align="left" rowspan="1" colspan="1">10.5</td>
                        <td align="left" rowspan="1" colspan="1">126</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">L angular gyrus</td>
                        <td align="left" rowspan="1" colspan="1">−50 −70 32</td>
                        <td align="left" rowspan="1" colspan="1">10.0</td>
                        <td align="left" rowspan="1" colspan="1">170</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Bilat precuneus</td>
                        <td align="left" rowspan="1" colspan="1">2 −58 38</td>
                        <td align="left" rowspan="1" colspan="1">10.0</td>
                        <td align="left" rowspan="1" colspan="1">412</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">R superior temporal gyrus</td>
                        <td align="left" rowspan="1" colspan="1">62 −24 −4</td>
                        <td align="left" rowspan="1" colspan="1">9.0</td>
                        <td align="left" rowspan="1" colspan="1">137</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="brb32475-tbl2-note-0001">
                      <p><italic toggle="yes">Note</italic>: All <italic toggle="yes">p</italic> &lt; .001.</p>
                    </fn>
                    <fn id="brb32475-tbl2-note-0002">
                      <p>Abbreviations: L, left; R, right; Bilat, bilateral; BSR, bootstrap ratio; MNI coords, Montreal Neurological Institute coordinates; DMN, default mode network; ESC, escitalopram; MEM, memantine; PBO, placebo.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <fig position="float" fig-type="FIGURE" id="brb32475-fig-0002">
                  <label>FIGURE 2</label>
                  <caption>
                    <p>Regions showing a stronger relationship between increased within‐network DMN connectivity following treatment and symptom improvement in the ESC/MEM group than in the ESC/PBO group. DMN, default mode network; ESC escitalopram; MEM, memantine; PBO, placebo</p>
                  </caption>
                  <graphic xlink:href="BRB3-12-e2475-g002" position="anchor" id="jats-graphic-3"/>
                </fig>
              </sec>
            </sec>
            <sec id="brb32475-sec-0150">
              <label>4</label>
              <title>DISCUSSION</title>
              <p>Escitalopram is a selective serotonin reuptake inhibitor used for the treatment of geriatric depression (Cipriani et al., <xref rid="brb32475-bib-0004" ref-type="bibr">2009</xref>; Wu et al., <xref rid="brb32475-bib-0038" ref-type="bibr">2008</xref>). Memantine is a low‐to‐moderate affinity noncompetitive NMDA receptor antagonist currently used to slow cognitive decline in patients with Alzheimer disease (Gellis et al., <xref rid="brb32475-bib-0009" ref-type="bibr">2009</xref>). Our parent RCT showed that combined ESC/MEM treatment was more effective than ESC/PBO treatment in improving depressive symptoms (in terms of MADRS scores) at 6 months and cognitive function at 12 months in patients with LLD and subjective memory complaints, and without dementia (Lavretsky et al., <xref rid="brb32475-bib-0021" ref-type="bibr">2020</xref>). Thus, ESC/MEM treatment may be effective in targeting both depression and memory impairment in older adults. However, little is known regarding the neurocircuitry underlying this additional benefit. In the present study, we evaluated the 3‐month change in within‐network DMN connectivity following treatment with ESC/MEM or ESC/PBO for LLD with subjective memory impairments, as well as, the relationship between DMN connectivity change and symptom improvement. We found that although overall differences in the change in within‐network DMN connectivity between the two groups failed to reach significance, the groups differed in the strength of the relationship between within‐network DMN connectivity increases and depressive symptom improvement as assessed by the MADRS. Increased within‐network connectivity of core posterior and lateral DMN nodes was more strongly positively correlated with symptom improvement in patients treated with ESC/MEM than in those treated with ESC/PBO.</p>
              <p>A previous treatment study evaluating within‐network DMN connectivity changes showed that changes in within‐network DMN connectivity can occur shortly after medication exposure, within 1 week for venlafaxine, depending on whether remission is subsequently achieved (Karim et al., <xref rid="brb32475-bib-0019" ref-type="bibr">2017</xref>). This result suggests that early changes in functional connectivity can predict better longer‐term clinical outcomes. Both groups in the present study showed similar symptom improvement over the 3‐month study period likely due to treatment with escitalopram, as well as, a similar change in within‐network DMN connectivity; however, the relationship between the increase in within‐network connectivity of key DMN regions and symptom improvement was stronger with the additional administration of memantine. This difference in the strength of the relationship between brain and behavioral changes suggest more robust functional reorganization relevant to depression with ESC/MEM than with ESC/PBO, possibly due to greater transcriptomic gene expression changes in the neuroplastic pathways with memantine treatment based on our previous report (Grzenda et al., <xref rid="brb32475-bib-0011" ref-type="bibr">2020</xref>). As early changes in functional connectivity may predict better longer‐term clinical outcomes, we speculate that this more robust functional reorganization underlies the better long‐term outcomes with ESC/MEM than with ESC/PBO observed in the larger parent study and transcriptome analyses (Grzenda et al., <xref rid="brb32475-bib-0011" ref-type="bibr">2020</xref>; Lavretsky et al., <xref rid="brb32475-bib-0021" ref-type="bibr">2020</xref>).</p>
              <p>Numerous studies have investigated the direction and nature of pathological DMN connectivity in depression, as well as, the impact of treatment on DMN connectivity, with conflicting results. Early neuroimaging studies on depression and dysthymia reported mainly increased DMN connectivity (Andreescu et al., <xref rid="brb32475-bib-0001" ref-type="bibr">2013</xref>; Hamilton et al., <xref rid="brb32475-bib-0014" ref-type="bibr">2015</xref>; Kaiser et al., <xref rid="brb32475-bib-0018" ref-type="bibr">2015</xref>; Li et al., <xref rid="brb32475-bib-0022" ref-type="bibr">2013</xref>; Posner et al., <xref rid="brb32475-bib-0033" ref-type="bibr">2013</xref>), suggesting that DMN connectivity reduction may be a treatment target. However, a recent large‐scale study showed more complex results, with increased orbitofrontal and decreased posterior DMN connectivity in MDD (Yan et al., <xref rid="brb32475-bib-0039" ref-type="bibr">2019</xref>). Although a previous MDD treatment study reported decreased within‐network connectivity for posterior DMN regions following antidepressant treatment, a prior LLD treatment study reported increased DMN connectivity for posterior DMN regions (precuneus) and decreased DMN connectivity for frontal regions (superior frontal and precentral gyri) following antidepressant treatment (Andreescu et al., <xref rid="brb32475-bib-0001" ref-type="bibr">2013</xref>). Another LLD study reported a greater increase in DMN connectivity in lateral DMN regions (middle temporal gyrus) and a greater DMN connectivity decrease in DMN connectivity in frontal regions (inferior frontal gyrus) following venlafaxine treatment in remitters than in non‐remitters (Andreescu et al., <xref rid="brb32475-bib-0001" ref-type="bibr">2013</xref>; Karim et al., <xref rid="brb32475-bib-0019" ref-type="bibr">2017</xref>). Consistent with these latter studies, the present study found that greater symptom improvement with standard antidepressant treatment using escitalopram correlated with increased within‐network connectivity of the posterior and lateral DMN regions (precuneus, angular gyrus, superior/middle temporal gyrus), and this relationship was strengthened with the addition of memantine. Overall, recent studies suggest increased within‐network connectivity of posterior/lateral DMN nodes as a target in ameliorating depressive symptoms.</p>
              <p>The present study has several limitations to acknowledge. Many patients who enrolled in our RCT were unable to participate in the neuroimaging component due to existing contraindications such as, metal implants, common among older adults, which resulted in a small sample size. Additionally, two different scanners were used. However, ICA methods, including ICA‐AROMA preprocessing, generally perform well, showing good spatial reproducibility and similar test‐retest reliability across scanners (Marchitelli et al., <xref rid="brb32475-bib-0023" ref-type="bibr">2016</xref>; Parkes et al., <xref rid="brb32475-bib-0032" ref-type="bibr">2018</xref>). Furthermore, the study design did not include an untreated control group. Finally, although there is consensus regarding the key nodes of the DMN, various methods can be used to define the DMN (e.g., ICA, precuneus seed correlation analysis, selection of ROIs based on the literature). This variability may account for some of the differences between studies regarding pathological within‐network DMN connectivity and antidepressant treatment effects on within‐network DMN connectivity, rendering it more difficult to reach a consensus regarding DMN‐related treatment targets.</p>
            </sec>
            <sec id="brb32475-sec-0160">
              <label>5</label>
              <title>CONCLUSIONS</title>
              <p>Increased within‐network connectivity of posterior and lateral nodes of the DMN under 3 months of escitalopram treatment correlated with greater improvement in depression severity. However, this relationship was increased with the addition of memantine compared to placebo, thus supporting our prior observations of a greater neuroplastic potential with the adjunct use of memantine for the treatment of geriatric depression. The present study also further supports the importance of the DMN in depression and adds to the limited literature on its role in treatment‐related effects in LLD. In addition, the present study supports an improved engagement of brain circuitry implicated in the amelioration of depressive symptoms with combined ESC/MEM treatment in adults with LLD and subjective memory complaints.</p>
            </sec>
            <sec sec-type="COI-statement" id="brb32475-sec-0180">
              <title>CONFLICT OF INTEREST</title>
              <p>The authors declare no conflicts of interest.</p>
            </sec>
            <sec id="brb32475-sec-0190">
              <sec disp-level="2" id="brb32475-sec-0200">
                <title>PEER REVIEW</title>
                <p>The peer review history for this article is available at <ext-link xlink:href="https://publons.com/publon/10.1002/brb3.2475" ext-link-type="uri">https://publons.com/publon/10.1002/brb3.2475</ext-link>
</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack id="brb32475-sec-0170">
              <title>ACKNOWLEDGMENT</title>
              <p>This work was funded by the NIH grants R01MH097892 and AT009198 to Helen Lavretsky, and further supported by the National Center for Advancing Translational Science (NCATS) UCLA CTSI under grant UL1TR001881.</p>
            </ack>
            <sec sec-type="data-availability" id="brb32475-sec-0210">
              <title>DATA AVAILABILITY STATEMENT</title>
              <p>The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p>
            </sec>
            <ref-list id="brb32475-bibl-0001">
              <title>REFERENCES</title>
              <ref id="brb32475-bib-0001">
                <mixed-citation publication-type="journal" id="brb32475-cit-0001"><string-name><surname>Andreescu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Tudorascu</surname>, <given-names>D. L.</given-names></string-name>, <string-name><surname>Butters</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Tamburo</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Patel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Price</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Karp</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Reynolds</surname>, <given-names>C. F.</given-names></string-name>, &amp; <string-name><surname>Aizenstein</surname>, <given-names>H.</given-names></string-name> (<year>2013</year>). <article-title>Resting state functional connectivity and treatment response in late‐life depression</article-title>. <source>Psychiatry Research</source>, <volume>214</volume>(<issue>3</issue>), <fpage>313</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2013.08.007</pub-id>
<pub-id pub-id-type="pmid">24144505</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0002">
                <mixed-citation publication-type="book" id="brb32475-cit-0002"><collab collab-type="authors">APA Association</collab>
. (<year>2013</year>). <source>Diagnostic and statistical manual of mental disorders</source> (<edition>5th ed.</edition>).</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0003">
                <mixed-citation publication-type="journal" id="brb32475-cit-0003"><string-name><surname>Beckmann</surname>, <given-names>C. F.</given-names></string-name>, &amp; <string-name><surname>Smith</surname>, <given-names>S. M.</given-names></string-name> (<year>2005</year>). <article-title>Tensorial extensions of independent component analysis for multisubject FMRI analysis</article-title>. <source>Neuroimage</source>, <volume>25</volume>(<issue>1</issue>), <fpage>294</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.10.043</pub-id>
<pub-id pub-id-type="pmid">15734364</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0004">
                <mixed-citation publication-type="journal" id="brb32475-cit-0004"><string-name><surname>Cipriani</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Santilli</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Furukawa</surname>, <given-names>T. A.</given-names></string-name>, <string-name><surname>Signoretti</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Nakagawa</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>McGuire</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Churchill</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Barbui</surname>, <given-names>C.</given-names></string-name> (<year>2009</year>). <article-title>Escitalopram versus other antidepressive agents for depression</article-title>. <source>Cochrane Database of Systematic Reviews (Online)</source>, (<issue>2</issue>), <elocation-id>CD006532</elocation-id>. <pub-id pub-id-type="doi">10.1002/14651858.CD006532.pub2</pub-id>
</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0005">
                <mixed-citation publication-type="journal" id="brb32475-cit-0005"><string-name><surname>Diniz</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Butters</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Albert</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Dew</surname>, <given-names>M. A.</given-names></string-name>, &amp; <string-name><surname>Reynolds</surname>, <given-names>C. F.</given-names><suffix>3rd.</suffix></string-name> (<year>2013</year>). <article-title>Late‐life depression and risk of vascular dementia and Alzheimer's disease: Systematic review and meta‐analysis of community‐based cohort studies</article-title>. <source>British Journal of Psychiatry</source>, <volume>202</volume>(<issue>5</issue>), <fpage>329</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.112.118307</pub-id>
</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0006">
                <mixed-citation publication-type="journal" id="brb32475-cit-0006"><string-name><surname>Esteban</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Birman</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Schaer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Koyejo</surname>, <given-names>O. O.</given-names></string-name>, <string-name><surname>Poldrack</surname>, <given-names>R. A.</given-names></string-name>, &amp; <string-name><surname>Gorgolewski</surname>, <given-names>K. J.</given-names></string-name> (<year>2017</year>). <article-title>MRIQC: Advancing the automatic prediction of image quality in MRI from unseen sites</article-title>. <source>Plos One</source>, <volume>12</volume>(<issue>9</issue>), <elocation-id>e0184661</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0184661</pub-id>
<pub-id pub-id-type="pmid">28945803</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0007">
                <mixed-citation publication-type="journal" id="brb32475-cit-0007"><string-name><surname>Esteban</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Markiewicz</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Blair</surname>, <given-names>R. W.</given-names></string-name>, <string-name><surname>Moodie</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Isik</surname>, <given-names>A. I.</given-names></string-name>, <string-name><surname>Erramuzpe</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kent</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Goncalves</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dupre</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Snyder</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Oya</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ghosh</surname>, <given-names>S. S.</given-names></string-name>, <string-name><surname>Wright</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Durnez</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Poldrack</surname>, <given-names>R. A.</given-names></string-name>, &amp; <string-name><surname>Gorgolewski</surname>, <given-names>K. J.</given-names></string-name> (<year>2019</year>). <article-title>fMRIPrep: A robust preprocessing pipeline for functional MRI</article-title>. <source>Nature Methods</source>, <volume>16</volume>(<issue>1</issue>), <fpage>111</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-018-0235-4</pub-id>
<pub-id pub-id-type="pmid">30532080</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0008">
                <mixed-citation publication-type="journal" id="brb32475-cit-0008"><string-name><surname>Folstein</surname>, <given-names>M. F.</given-names></string-name>, <string-name><surname>Folstein</surname>, <given-names>S. E.</given-names></string-name>, &amp; <string-name><surname>McHugh</surname>, <given-names>P. R.</given-names></string-name> (<year>1975</year>). <article-title>Mini‐mental state. A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>Journal of Psychiatric Research</source>, <volume>12</volume>(<issue>3</issue>), <fpage>189</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1016/0022-3956(75)90026-6</pub-id>
<pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0009">
                <mixed-citation publication-type="journal" id="brb32475-cit-0009"><string-name><surname>Gellis</surname>, <given-names>Z. D.</given-names></string-name>, <string-name><surname>McClive‐Reed</surname>, <given-names>K. P.</given-names></string-name>, &amp; <string-name><surname>Brown</surname>, <given-names>E.</given-names></string-name> (<year>2009</year>). <article-title>Treatments for depression in older persons with dementia</article-title>. <source>Ann Longterm Care</source>, <volume>17</volume>(<issue>2</issue>), <fpage>29</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">21814486</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0010">
                <mixed-citation publication-type="journal" id="brb32475-cit-0010"><string-name><surname>Greicius</surname>, <given-names>M. D.</given-names></string-name>, &amp; <string-name><surname>Menon</surname>, <given-names>V.</given-names></string-name> (<year>2004</year>). <article-title>Default‐mode activity during a passive sensory task: Uncoupled from deactivation but impacting activation</article-title>. <source>Journal of Cognitive Neuroscience</source>, <volume>16</volume>(<issue>9</issue>), <fpage>1484</fpage>–<lpage>1492</lpage>. <pub-id pub-id-type="doi">10.1162/0898929042568532</pub-id>
<pub-id pub-id-type="pmid">15601513</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0011">
                <mixed-citation publication-type="journal" id="brb32475-cit-0011"><string-name><surname>Grzenda</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Siddarth</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Laird</surname>, <given-names>K. T.</given-names></string-name>, <string-name><surname>Yeargin</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Lavretsky</surname>, <given-names>H.</given-names></string-name> (<year>2020</year>). <article-title>Transcriptomic signatures of treatment response to the combination of escitalopram and memantine or placebo in late‐life depression</article-title>. <source>Molecular Psychiatry</source>, <volume>26</volume>, <fpage>5171</fpage>–<lpage>5179</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-020-0752-2</pub-id>
<pub-id pub-id-type="pmid">32382137</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0012">
                <mixed-citation publication-type="journal" id="brb32475-cit-0012"><string-name><surname>Gusnard</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Akbudak</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Shulman</surname>, <given-names>G. L.</given-names></string-name>, &amp; <string-name><surname>Raichle</surname>, <given-names>M. E.</given-names></string-name> (<year>2001</year>). <article-title>Medial prefrontal cortex and self‐referential mental activity: Relation to a default mode of brain function</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>98</volume>(<issue>7</issue>), <fpage>4259</fpage>–<lpage>4264</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.071043098</pub-id>
<pub-id pub-id-type="pmid">11259662</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0013">
                <mixed-citation publication-type="book" id="brb32475-cit-0013"><string-name><surname>Guy</surname>, <given-names>W.</given-names></string-name> (<year>1976</year>). <part-title>Clinical global impressions (CGI)</part-title>. In <source>ECDEU assessment manual for psychopharmacology</source> (pp. <fpage>218</fpage>–<lpage>222</lpage>). <publisher-name>Alcohol Drug Abuse and Mental Health Administration</publisher-name>.</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0014">
                <mixed-citation publication-type="journal" id="brb32475-cit-0014"><string-name><surname>Hamilton</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Farmer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Fogelman</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Gotlib</surname>, <given-names>I. H.</given-names></string-name> (<year>2015</year>). <article-title>Depressive rumination, the default‐mode network, and the dark matter of clinical neuroscience</article-title>. <source>Biological Psychiatry</source>, <volume>78</volume>(<issue>4</issue>), <fpage>224</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.02.020</pub-id>
<pub-id pub-id-type="pmid">25861700</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0015">
                <mixed-citation publication-type="journal" id="brb32475-cit-0015"><string-name><surname>Hamilton</surname>, <given-names>M.</given-names></string-name> (<year>1960</year>). <article-title>A rating scale for depression</article-title>. <source>Journal of Neurology, Neurosurgery, and Psychiatry</source>, <volume>23</volume>, <fpage>56</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.23.1.56</pub-id>
</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0016">
                <mixed-citation publication-type="journal" id="brb32475-cit-0016"><string-name><surname>Iacoboni</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lieberman</surname>, <given-names>M. D.</given-names></string-name>, <string-name><surname>Knowlton</surname>, <given-names>B. J.</given-names></string-name>, <string-name><surname>Molnar‐Szakacs</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Moritz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Throop</surname>, <given-names>C. J.</given-names></string-name>, &amp; <string-name><surname>Fiske</surname>, <given-names>A. P.</given-names></string-name> (<year>2004</year>). <article-title>Watching social interactions produces dorsomedial prefrontal and medial parietal BOLD fMRI signal increases compared to a resting baseline</article-title>. <source>Neuroimage</source>, <volume>21</volume>(<issue>3</issue>), <fpage>1167</fpage>–<lpage>1173</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2003.11.013</pub-id>
<pub-id pub-id-type="pmid">15006683</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0017">
                <mixed-citation publication-type="journal" id="brb32475-cit-0017"><string-name><surname>Ismail</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Fischer</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>McCall</surname>, <given-names>W. V.</given-names></string-name> (<year>2013</year>). <article-title>What characterizes late‐life depression?</article-title>
<source>The Psychiatric Clinics of North America</source>, <volume>36</volume>(<issue>4</issue>), <fpage>483</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/j.psc.2013.08.010</pub-id>
<pub-id pub-id-type="pmid">24229652</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0018">
                <mixed-citation publication-type="journal" id="brb32475-cit-0018"><string-name><surname>Kaiser</surname>, <given-names>R. H.</given-names></string-name>, <string-name><surname>Andrews‐Hanna</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Wager</surname>, <given-names>T. D.</given-names></string-name>, &amp; <string-name><surname>Pizzagalli</surname>, <given-names>D. A.</given-names></string-name> (<year>2015</year>). <article-title>Large‐scale network dysfunction in major depressive disorder: A meta‐analysis of resting‐state functional connectivity</article-title>. <source>JAMA Psychiatry</source>, <volume>72</volume>(<issue>6</issue>), <fpage>603</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.0071</pub-id>
<pub-id pub-id-type="pmid">25785575</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0019">
                <mixed-citation publication-type="journal" id="brb32475-cit-0019"><string-name><surname>Karim</surname>, <given-names>H. T.</given-names></string-name>, <string-name><surname>Andreescu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Tudorascu</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Smagula</surname>, <given-names>S. F.</given-names></string-name>, <string-name><surname>Butters</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Karp</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Reynolds</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Aizenstein</surname>, <given-names>H. J.</given-names></string-name> (<year>2017</year>). <article-title>Intrinsic functional connectivity in late‐life depression: Trajectories over the course of pharmacotherapy in remitters and non‐remitters</article-title>. <source>Molecular Psychiatry</source>, <volume>22</volume>(<issue>3</issue>), <fpage>450</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.55</pub-id>
<pub-id pub-id-type="pmid">27090303</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0020">
                <mixed-citation publication-type="journal" id="brb32475-cit-0020"><string-name><surname>Krishnan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>McIntosh</surname>, <given-names>A. R.</given-names></string-name>, &amp; <string-name><surname>Abdi</surname>, <given-names>H.</given-names></string-name> (<year>2011</year>). <article-title>Partial least squares (PLS) methods for neuroimaging: A tutorial and review</article-title>. <source>Neuroimage</source>, <volume>56</volume>(<issue>2</issue>), <fpage>455</fpage>–<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.07.034</pub-id>
<pub-id pub-id-type="pmid">20656037</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0021">
                <mixed-citation publication-type="journal" id="brb32475-cit-0021"><string-name><surname>Lavretsky</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Laird</surname>, <given-names>K. T.</given-names></string-name>, <string-name><surname>Krause‐Sorio</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Heimberg</surname>, <given-names>B. F.</given-names></string-name>, <string-name><surname>Yeargin</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Grzenda</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Thana‐Udom</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ercoli</surname>, <given-names>L. M.</given-names></string-name>, &amp; <string-name><surname>Siddarth</surname>, <given-names>P.</given-names></string-name> (<year>2020</year>). <article-title>A randomized double‐blind placebo‐controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory complaints</article-title>. <source>American Journal of Geriatric Psychiatry</source>, <volume>28</volume>(<issue>2</issue>), <fpage>178</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.jagp.2019.08.011</pub-id>
</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0022">
                <mixed-citation publication-type="journal" id="brb32475-cit-0022"><string-name><surname>Li</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Friston</surname>, <given-names>K. J.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zeng</surname>, <given-names>L. L.</given-names></string-name>, &amp; <string-name><surname>Hu</surname>, <given-names>D.</given-names></string-name> (<year>2013</year>). <article-title>A treatment‐resistant default mode subnetwork in major depression</article-title>. <source>Biological Psychiatry</source>, <volume>74</volume>(<issue>1</issue>), <fpage>48</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2012.11.007</pub-id>
<pub-id pub-id-type="pmid">23273724</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0023">
                <mixed-citation publication-type="journal" id="brb32475-cit-0023"><string-name><surname>Marchitelli</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Minati</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Marizzoni</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bosch</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Bartres‐Faz</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Muller</surname>, <given-names>B. W.</given-names></string-name>, <string-name><surname>Wiltfang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fiedler</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Roccatagliata</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Picco</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Nobili</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Blin</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Bombois</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lopes</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Bordet</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Sein</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ranjeva</surname>, <given-names>J.‐P.</given-names></string-name>, <string-name><surname>Didic</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gros‐Dagnac</surname>, <given-names>H.</given-names></string-name>, …, <string-name><surname>Jovicich</surname>, <given-names>J.</given-names></string-name> (<year>2016</year>). <article-title>Test‐retest reliability of the default mode network in a multi‐centric fMRI study of healthy elderly: Effects of data‐driven physiological noise correction techniques</article-title>. <source>Human Brain Mapping</source>, <volume>37</volume>(<issue>6</issue>), <fpage>2114</fpage>–<lpage>2132</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.23157</pub-id>
<pub-id pub-id-type="pmid">26990928</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0024">
                <mixed-citation publication-type="journal" id="brb32475-cit-0024"><string-name><surname>McIntosh</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Bookstein</surname>, <given-names>F. L.</given-names></string-name>, <string-name><surname>Haxby</surname>, <given-names>J. V.</given-names></string-name>, &amp; <string-name><surname>Grady</surname>, <given-names>C. L.</given-names></string-name> (<year>1996</year>). <article-title>Spatial pattern analysis of functional brain images using partial least squares</article-title>. <source>Neuroimage</source>, <volume>3</volume>(<issue>3 Pt 1</issue>), <fpage>143</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1006/nimg.1996.0016</pub-id>
<pub-id pub-id-type="pmid">9345485</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0025">
                <mixed-citation publication-type="journal" id="brb32475-cit-0025"><string-name><surname>McIntosh</surname>, <given-names>A. R.</given-names></string-name>, &amp; <string-name><surname>Lobaugh</surname>, <given-names>N. J.</given-names></string-name> (<year>2004</year>). <article-title>Partial least squares analysis of neuroimaging data: Applications and advances</article-title>. <source>Neuroimage</source>, <volume>23</volume>(<issue>1</issue>), <fpage>S250</fpage>–<lpage>S263</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.07.020</pub-id>
<pub-id pub-id-type="pmid">15501095</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0026">
                <mixed-citation publication-type="journal" id="brb32475-cit-0026"><string-name><surname>McShane</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Areosa Sastre</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Minakaran</surname>, <given-names>N.</given-names></string-name> (<year>2006</year>). <article-title>Memantine for dementia</article-title>. <source>Cochrane Database of Systematic Reviews (Online)</source>, (<issue>2</issue>), <elocation-id>CD003154</elocation-id>. <pub-id pub-id-type="doi">10.1002/14651858.CD003154.pub5</pub-id>
</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0027">
                <mixed-citation publication-type="journal" id="brb32475-cit-0027"><string-name><surname>Mitchell</surname>, <given-names>A. J.</given-names></string-name>, &amp; <string-name><surname>Subramaniam</surname>, <given-names>H.</given-names></string-name> (<year>2005</year>). <article-title>Prognosis of depression in old age compared to middle age: A systematic review of comparative studies</article-title>. <source>American Journal of Psychiatry</source>, <volume>162</volume>(<issue>9</issue>), <fpage>1588</fpage>–<lpage>1601</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.162.9.1588</pub-id>
</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0028">
                <mixed-citation publication-type="journal" id="brb32475-cit-0028"><string-name><surname>Montgomery</surname>, <given-names>S. A.</given-names></string-name>, &amp; <string-name><surname>Asberg</surname>, <given-names>M.</given-names></string-name> (<year>1979</year>). <article-title>A new depression scale designed to be sensitive to change</article-title>. <source>British Journal of Psychiatry</source>, <volume>134</volume>, <fpage>382</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.134.4.382</pub-id>
</mixed-citation>
              </ref>
              <ref id="brb32475-bib-0029">
                <mixed-citation publication-type="journal" id="brb32475-cit-0029"><string-name><surname>Mourao</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Mansur</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Malloy‐Diniz</surname>, <given-names>L. F.</given-names></string-name>, <string-name><surname>Castro Costa</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Diniz</surname>, <given-names>B. S.</given-names></string-name> (<year>2016</year>). <article-title>Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: Systematic review and meta‐analysis</article-title>. <source>International Journal of Geriatric Psychiatry</source>, <volume>31</volume>(<issue>8</issue>), <fpage>905</fpage>–<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1002/gps.4406</pub-id>
<pub-id pub-id-type="pmid">26680599</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0030">
                <mixed-citation publication-type="journal" id="brb32475-cit-0030"><string-name><surname>Nebes</surname>, <given-names>R. D.</given-names></string-name>, <string-name><surname>Pollock</surname>, <given-names>B. G.</given-names></string-name>, <string-name><surname>Houck</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Butters</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Mulsant</surname>, <given-names>B. H.</given-names></string-name>, <string-name><surname>Zmuda</surname>, <given-names>M. D.</given-names></string-name>, &amp; <string-name><surname>Reynolds</surname>, <given-names>C. F.</given-names><suffix>3rd.</suffix></string-name> (<year>2003</year>). <article-title>Persistence of cognitive impairment in geriatric patients following antidepressant treatment: A randomized, double‐blind clinical trial with nortriptyline and paroxetine</article-title>. <source>Journal of Psychiatric Research</source>, <volume>37</volume>(<issue>2</issue>), <fpage>99</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3956(02)00085-7</pub-id>
<pub-id pub-id-type="pmid">12842163</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0031">
                <mixed-citation publication-type="journal" id="brb32475-cit-0031"><string-name><surname>Nickerson</surname>, <given-names>L. D.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Ongur</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Beckmann</surname>, <given-names>C. F.</given-names></string-name> (<year>2017</year>). <article-title>Using dual regression to investigate network shape and amplitude in functional connectivity analyses</article-title>. <source>Frontiers in Neuroscience</source>, <volume>11</volume>, <elocation-id>115</elocation-id>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00115</pub-id>
<pub-id pub-id-type="pmid">28348512</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0032">
                <mixed-citation publication-type="journal" id="brb32475-cit-0032"><string-name><surname>Parkes</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Fulcher</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Yucel</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Fornito</surname>, <given-names>A.</given-names></string-name> (<year>2018</year>). <article-title>An evaluation of the efficacy, reliability, and sensitivity of motion correction strategies for resting‐state functional MRI</article-title>. <source>Neuroimage</source>, <volume>171</volume>, <fpage>415</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.12.073</pub-id>
<pub-id pub-id-type="pmid">29278773</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0033">
                <mixed-citation publication-type="journal" id="brb32475-cit-0033"><string-name><surname>Posner</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hellerstein</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Gat</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Mechling</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Klahr</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Mcgrath</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Stewart</surname>, <given-names>J. W.</given-names></string-name>, &amp; <string-name><surname>Peterson</surname>, <given-names>B. S.</given-names></string-name> (<year>2013</year>). <article-title>Antidepressants normalize the default mode network in patients with dysthymia</article-title>. <source>JAMA Psychiatry</source>, <volume>70</volume>(<issue>4</issue>), <fpage>373</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.455</pub-id>
<pub-id pub-id-type="pmid">23389382</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0034">
                <mixed-citation publication-type="journal" id="brb32475-cit-0034"><string-name><surname>Pruim</surname>, <given-names>R. H. R.</given-names></string-name>, <string-name><surname>Mennes</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>van Rooij</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Llera</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Buitelaar</surname>, <given-names>J. K.</given-names></string-name>, &amp; <string-name><surname>Beckmann</surname>, <given-names>C. F.</given-names></string-name> (<year>2015</year>). <article-title>ICA‐AROMA: A robust ICA‐based strategy for removing motion artifacts from fMRI data</article-title>. <source>Neuroimage</source>, <volume>112</volume>, <fpage>267</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.02.064</pub-id>
<pub-id pub-id-type="pmid">25770991</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0035">
                <mixed-citation publication-type="journal" id="brb32475-cit-0035"><string-name><surname>Singh‐Manoux</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Dugravot</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fournier</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Abell</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ebmeier</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kivimaki</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Sabia</surname>, <given-names>S.</given-names></string-name> (<year>2017</year>). <article-title>Trajectories of depressive symptoms before diagnosis of dementia: A 28‐year follow‐up study</article-title>. <source>JAMA Psychiatry</source>, <volume>74</volume>(<issue>7</issue>), <fpage>712</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.0660</pub-id>
<pub-id pub-id-type="pmid">28514478</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0036">
                <mixed-citation publication-type="journal" id="brb32475-cit-0036"><string-name><surname>Wilkins</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Mathews</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Sheline</surname>, <given-names>Y. I.</given-names></string-name> (<year>2009</year>). <article-title>Late life depression with cognitive impairment: Evaluation and treatment</article-title>. <source>Clinical Interventions in Aging</source>, <volume>4</volume>, <fpage>51</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">19503765</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0037">
                <mixed-citation publication-type="journal" id="brb32475-cit-0037"><string-name><surname>Winkler</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Ridgway</surname>, <given-names>G. R.</given-names></string-name>, <string-name><surname>Webster</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>S. M.</given-names></string-name>, &amp; <string-name><surname>Nichols</surname>, <given-names>T. E.</given-names></string-name> (<year>2014</year>). <article-title>Permutation inference for the general linear model</article-title>. <source>Neuroimage</source>, <volume>92</volume>, <fpage>381</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.01.060</pub-id>
<pub-id pub-id-type="pmid">24530839</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0038">
                <mixed-citation publication-type="journal" id="brb32475-cit-0038"><string-name><surname>Wu</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Greenberg</surname>, <given-names>P. E.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Erder</surname>, <given-names>M. H.</given-names></string-name> (<year>2008</year>). <article-title>Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population</article-title>. <source>Current Medical Research and Opinion</source>, <volume>24</volume>(<issue>9</issue>), <fpage>2587</fpage>–<lpage>2595</lpage>. <pub-id pub-id-type="doi">10.1185/03007990802303525</pub-id>
<pub-id pub-id-type="pmid">18674407</pub-id></mixed-citation>
              </ref>
              <ref id="brb32475-bib-0039">
                <mixed-citation publication-type="journal" id="brb32475-cit-0039"><string-name><surname>Yan</surname>, <given-names>C. G.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Castellanos</surname>, <given-names>F. X.</given-names></string-name>, <string-name><surname>Bai</surname>, <given-names>T. J.</given-names></string-name>, <string-name><surname>Bo</surname>, <given-names>Q. J.</given-names></string-name>, <string-name><surname>Cao</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>G.‐M.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>N.‐X.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>Y.‐Q.</given-names></string-name>, <string-name><surname>Cui</surname>, <given-names>X.‐L.</given-names></string-name>, <string-name><surname>Duan</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fang</surname>, <given-names>Y.‐R.</given-names></string-name>, <string-name><surname>Gong</surname>, <given-names>Q.‐Y.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>W.‐B.</given-names></string-name>, <string-name><surname>Hou</surname>, <given-names>Z.‐H.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>L.</given-names></string-name>, … <string-name><surname>Zang</surname>, <given-names>Y. F.</given-names></string-name> (<year>2019</year>). <article-title>Reduced default mode network functional connectivity in patients with recurrent major depressive disorder</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>116</volume>(<issue>18</issue>), <fpage>9078</fpage>–<lpage>9083</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1900390116</pub-id>
<pub-id pub-id-type="pmid">30979801</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
